Učitavanje...
HLA Haplotype Mismatch Transplants and Posttransplant Cyclophosphamide
The use of high dose posttransplant cyclophosphamide (PT-CY) introduced by the Baltimore group approximately 10 years ago has been rapidly adopted worldwide and is becoming a standard for patients undergoing unmanipulated haploidentical (HAPLO) transplants. PT-CY has been used following nonmyeloabla...
Spremljeno u:
| Izdano u: | Adv Hematol |
|---|---|
| Glavni autori: | , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Hindawi Publishing Corporation
2016
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4838781/ https://ncbi.nlm.nih.gov/pubmed/27143973 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2016/7802967 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|